Island Pharmaceuticals Ltd Sustainability Reports
Island Pharmaceuticals Limited is a mid-clinical stage drug repurposing company focused on the rapid development of antiviral therapeutics. Its primary programs target infectious diseases such as dengue fever and Zika virus.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 5299007AAXFWP52UC792
FIGI: BBG00ZK1B0V0
5 reports from 2021 to 2025
